ATM program
Issued 2023
Total capacity
Sold to date
Remaining capacity
- Sales agent
- Agreement date
- Commission
PEPG$2.43+3.40%
PepGen Inc.
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$168.3M
Float & O/S:
Inst Own:
DilutionScan read 32 of PepGen Inc.'s SEC filings and found 2 ATM programs, 3 shelf registrations and 1 completed offering on file for PEPG. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Oct 6, 2026.
Signal8 Summary
5d old
PEPG
Pre-revenue biotech burning cash, heavy dilution
- Business
- WeakNo revenue, $89.7M net loss, 18.3-month runway
- Stock risk
- HighShares +33.7% YoY, 57.2% overhead dilution, near 52w low
Snapshot
PepGen is a clinical-stage biotech with no revenue, developing treatments for a muscular disease currently in Phase 2 trials. FY 2025 net loss was $89.7M, roughly in line with prior years, and free cash flow was negative $81.9M.
What's Happening Right Now
- : On Oct 5, 2026, MarketBeat reported PepGen holds a 'Moderate Buy' consensus from six covering analysts, with five buy and one sell rating.
- : On Aug 6, 2026, PepGen reported a Q2 2026 net loss of $0.26 per share with $117.2 million in cash, which it says funds operations into Q4 2027.
- : On Aug 6, 2026, an independent safety board recommended advancing PepGen's Phase 2 FREEDOM2-DM1 study to the highest 12.5 mg/kg dose with no protocol changes, citing no serious adverse events; 10 mg/kg cohort data is expected in November and 12.5 mg/kg data in first half 2027.
- : Sold $1.50M net / 238K shares through its at-the-market program, as stated for Jan 1, 2026 to Jun 30, 2026.
- : Registered $400.00M of securities for sale on Form S-3.
- : Sold $1.51M net / 238K shares through its at-the-market program, as stated for Jan 1, 2026 to Mar 31, 2026.
Raise routes on file: active ATM + effective shelf · latest dilution event 126 days ago
Overall Risk
Offering Ability
Overhead Supply
Historical
Cash Need
AI dilution summary
The dominant contractual driver and its mechanism, then each further driver ranked.
Latest dilution event
Jun 30, 2026 · ATM Sale
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Share count and cash history
Shares outstanding, potential dilution and cash over time
Replaced
ATM program
Issued 2026
Total capacity
Sold to date
Remaining capacity
- Sales agent
- Agreement date
- Commission
S-3 shelf registration
Issued 2026
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
S-3 shelf registration
Issued 2024
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
S-3 shelf registration
Issued 2023
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
Public offering
Issued 2025
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Know who's about to sell into your PEPG trade
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
